5-Aminolevulinic acid hydrochloride enhances bupivacaine-induced hypotension in spontaneously hypertensive rats
Journal of Pharmacological Sciences · 2023
DOI: 10.1016/j.jphs.2023.02.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacological Sciences, 2023. Verfasst von Noboru Fukuda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan; Division …. Hauptthemen laut MEDLINE: Hypotension, Controlled, Propofol, Hypertension, Hypotension. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
PURPOSE: Oral administration of 5-aminolevulinic acid hydrochloride (5-ALA-HCl) has been reported to enhance the hypotensive effects associated with anesthetics, especially in elderly hypertensive patients treated with antihypertensive agents. The present study aimed to clarify the effects of antihypertensive-agent- and anesthesia-induced hypotension by 5-ALA-HCl in spontaneously hypertensive rats (SHRs). METHODS: We measured blood pressure (BP) of SHRs and normotensive Wistar Kyoto (WKY) rats treated with amlodipine or candesartan before and after administration of 5-ALA-HCl. We also investigated the change in BP following intravenous infusion of propofol and intrathecal injection of bupivacaine in relation to 5-ALA-HCl administration. FINDINGS: Oral administration of 5-ALA-HCl significantly reduced BP in SHRs and WKY rats with amlodipine and candesartan. Infusion of propofol significantly reduced BP in SHRs treated with 5-ALA-HCl. Intrathecal injection of bupivacaine significantly declined SBP and DBP in both SHRs and WKY rats treated with 5-ALA-HCl. The bupivacaine-induced decline in SBP was significantly larger in SHRs compared with WKY rats. CONCLUSION: These findings suggest that 5-ALA-HCl does not affect the antihypertensive agents-induced hypotensive effect, but enhances the bupivacaine-induced hypotensive effect, especially in SHRs, indicating that 5-ALA may contribute to anesthesia-induced hypotension via suppression of sympathetic nerve activity in patients with hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan; Division of Cell Regeneration and Transplantation, Department of Functional Mor…
- Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan.
- SBI Pharmaceuticals Co., Ltd., 1-6-1 Roppongi, Minato-ku, Tokyo, 106-6020, Japan.
- Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan. Electronic address: abe.masanori@nihon-u.ac.jp.
Zitieren
APA
Fukuda, N., Katakawa, M., Ito, H., Hara, T., Otsuka, N., Ishizuka, M., & Abe, M. (2023). 5-Aminolevulinic acid hydrochloride enhances bupivacaine-induced hypotension in spontaneously hypertensive rats. Journal of Pharmacological Sciences. https://doi.org/10.1016/j.jphs.2023.02.007
Vancouver
Fukuda N, Katakawa M, Ito H, Hara T, Otsuka N, Ishizuka M, et al. 5-Aminolevulinic acid hydrochloride enhances bupivacaine-induced hypotension in spontaneously hypertensive rats. Journal of Pharmacological Sciences. 2023. doi:10.1016/j.jphs.2023.02.007
BibTeX
@article{Fukuda2023,
author = {Fukuda, Noboru and Katakawa, Mayumi and Ito, Hidenori and Hara, Takeshi and Otsuka, Noboru and Ishizuka, Masahiro and Abe, Masanori},
title = {5-Aminolevulinic acid hydrochloride enhances bupivacaine-induced hypotension in spontaneously hypertensive rats},
journal = {Journal of Pharmacological Sciences},
year = {2023},
doi = {10.1016/j.jphs.2023.02.007}
}
EUVIMED